Skip to main content
. 2022 Dec 13;14(12):2783. doi: 10.3390/pharmaceutics14122783
Dox Doxorubicin
EPR Enhanced permeation and retention
ER Estrogen receptor
FA Folic acid
FDA Food and Drug Administration
HER2 Human epidermal growth receptor 2
IV Intravenous
miRNA Micro ribonucleic acid
NPs Nanoparticles
PDT Photodynamic treatment
PAMAM Polyamidoamine
PEG Polyethylene glycol
PLA Polylactic acid
PR Progesterone receptor
PS Photosensitizer
QDs Quantum dots
ROS Reactive oxygen species
siRNA Small interfering ribonucleic acid
TNBC Triple-negative breast cancer